Transcrip offers experts to augment in-house drug development

Transcrip offers experts to augment in-house drug development

4 Minuten

Beschreibung

vor 16 Jahren
Transcrip Partners’ “augmentation” solution for contract R&D
“differs from the normal consultancy alternative by fielding
‘doers’ who can think strategically and ‘thinkers’ who are happy to
get their hands dirty” according to senior partner Paul
Branthwaite.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15